Hepatitis B immune globulin and Hbv-related liver transplantation [Hepatit B immun globulin ve HBV nedeni ile karaciğer transplantasyonu]

The risk of recurrence of liver cirrhosis and hepatocellular carcinoma due to hepatitis B virus (HBV) infection was 90% following liver transplantation before 1990’s but now we rarely see recurrence due to the highly effective prophylactic treatments. In this review, we discussed the achievements of the prophylactic treatments in patients transplanted for HBV diseases. Options for hyperimmune globulin usage and high genetic barier anti-viral drugs can be used to prevent the recurrence. © 2017, Marmara University. All rights reserved.